title: [Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring].
abstract: OBJECTIVE
  To discuss the modes for smooth progress of ADR monitoring under the new Measures for the Administration of Adverse Drug Reaction Report and Monitoring.
  
  
  METHODS
  Work modes for ADR monitoring in drug manufacturers were explored by explaining the new Measures and analyzing current state and constrains.
  
  
  CONCLUSIONS
  As there is a larger gap between the requirements of new Measures and current status, it is difficult for drug manufacturers to meet all the requirements in short-term. Therefore, drug manufacturers are suggested to gradually complete ADR monitoring under the mode of one platform and four expansions, and thereby finally meeting the requirements of new Measures and fulfilling their duties and missions.
authors: Collage of Phamaceutical, Chongqing Medical University, Chongqing 400016, China.
authors: Yan-Yin
authors: YY
authors: Yang
authors: Zhi
authors: Z
authors: Dong
authors: Yong-Peng
authors: YP
authors: Xia
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis*; D006801:Humans